Your browser doesn't support javascript.
loading
Combination of oxaliplatin andβ-carotene suppresses colorectalcancer by regulating cell cycle, apoptosis, and cancer stemness in vitro
Article en En | WPRIM | ID: wpr-1045047
Biblioteca responsable: WPRO
ABSTRACT
BACKGROUND/OBJECTIVES@#Colorectal cancer (CRC) is the third most common cancer worldwide with a high recurrence rate. Oxaliplatin (OXA) resistance is one of the major reasons hindering CRC therapy. β-Carotene (BC) is a provitamin A and is known to have antioxidant and anticancer effects. However, the combined effect of OXA and BC has not been investigated. Therefore, this study investigated the anticancer effects and mechanism of the combination of OXA and BC on CRC.MATERIALS/METHODS: In the present study, the effects of the combination of OXA and BC on cell viability, cell cycle arrest, and cancer stemness were investigated using HCT116, HT29, OXA-resistant cells, and human CRC organoids. @*RESULTS@#The combination of OXA and BC enhanced apoptosis, G 2,/sub> /M phase cell cycle arrest, and inhibited cancer cell survival in human CRC resistant cells and CRC organoids without toxicity in normal organoids. Cancer stem cell marker expression and self-replicating capacity were suppressed by combined treatment with OXA and BC. Moreover, this combined treatment upregulated apoptosis and the stem cell-related JAK/STAT signaling pathway. @*CONCLUSIONS@#Our results suggest a novel potential role of BC in reducing resistance to OXA, thereby enhances the anticancer effects of OXA. This enhancement is achieved through the regulation of cell cycle, apoptosis, and stemness in CRC.
Texto completo: 1 Base de datos: WPRIM Idioma: En Revista: Nutrition Research and Practice Año: 2024 Tipo del documento: Article
Texto completo: 1 Base de datos: WPRIM Idioma: En Revista: Nutrition Research and Practice Año: 2024 Tipo del documento: Article